Sponsor:
Arsenal Medical, Inc.
Code:
NCT02880163
Conditions
Hemorrhagic Shock
Trauma
Exsanguinating Hemorrhage
Shock; Traumatic
Eligibility Criteria
Sex: All
Age: 15+
Healthy Volunteers: Not accepted
Interventions
ResQFoam
Brief summary:
Conditions
Hemorrhagic Shock
Trauma
Exsanguinating Hemorrhage
Shock; Traumatic
Study ID
NCT02880163
Start date
Aug 7, 2025
Status verified date
Nov, 2025
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Oct 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 15+
Healthy Volunteers: Not accepted
Enrollment
40 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: ResQFoam
Interventions
ResQFoam
Primary outcome measure
Central contacts
Locations
University of Alabama at Birmingham
Recruiting
Birmingham, Alabama, United States, 35294
Contacts
Principal Investigator:
William P Hewgley, MD
University of Cincinnati
Recruiting
Cincinnati, Ohio, United States, 45219
Contacts
Principal Investigator:
Timothy Pritts, MD
Sponsor
Arsenal Medical, Inc.
Last update posted
Nov 10, 2025
Last verified
Nov, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Arsenal Medical, Inc. on 2025-11-10.